The relationship between oxidative/nitrative stress and pathological inclusions in Alzheimer's and Parkinson's diseases.
about
Diet and Alzheimer’s disease risk factors or prevention: the current evidenceSignaling pathways mediating a selective induction of nitric oxide synthase II by tumor necrosis factor alpha in nerve growth factor-responsive cellsMicroglial cell dysregulation in brain aging and neurodegenerationResveratrol: A Focus on Several Neurodegenerative DiseasesThe crystal structure of DJ-1, a protein related to male fertility and Parkinson's diseaseCrystal structure of DJ-1/RS and implication on familial Parkinson's diseaseCrystal structures of human DJ-1 and Escherichia coli Hsp31, which share an evolutionarily conserved domainProtein carbonylation, cellular dysfunction, and disease progressionIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesRedox proteomics in selected neurodegenerative disorders: from its infancy to future applications.Pomegranate juice exacerbates oxidative stress and nigrostriatal degeneration in Parkinson's disease.Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseasesProducts of Cu(II)-catalyzed oxidation of alpha-synuclein fragments containing M1-D2 and H50 residues in the presence of hydrogen peroxide.Involvement of astroglial ceramide in palmitic acid-induced Alzheimer-like changes in primary neurons.Oxidative stress, mitochondrial damage and neurodegenerative diseasesBiomarkers of Alzheimer's disease risk in peripheral tissues; focus on buccal cells.Effects of Various Flavonoids on the α-Synuclein Fibrillation Process.Mediterranean diet, Alzheimer disease, and vascular mediationMediterranean diet and essential tremor. A case-control study.Doxycycline Suppresses Microglial Activation by Inhibiting the p38 MAPK and NF-kB Signaling Pathways.Interplay between oxidative damage, protein synthesis, and protein degradation in Alzheimer's diseaseNO synthase 2 (NOS2) deletion promotes multiple pathologies in a mouse model of Alzheimer's disease.Oxidative stress, cell cycle, and neurodegeneration.Melatonin protects against neurobehavioral and mitochondrial deficits in a chronic mouse model of Parkinson's diseaseCrystallizing ideas about Parkinson's diseaseCharacterization of cellular protective effects of ATP13A2/PARK9 expression and alterations resulting from pathogenic mutants.A Comparison of Total Antioxidant Capacities of Concord, Purple, Red, and Green Grapes Using the CUPRAC Assay.Lysophosphatidic acid induces increased BACE1 expression and Aβ formation.Mitochondria-targeted peptide antioxidants: novel neuroprotective agentsInteractions between metals and alpha-synuclein--function or artefact?Mass spectrometry-based proteomics and peptidomics for biomarker discovery in neurodegenerative diseasesHYPERHOMOCYSTEINEMIA AND ITS TREATMENT IN PATIENTS WITH PARKINSON'S DISEASE.Commonalities in the genetics of Alzheimer's disease and Parkinson's disease.Unbiased screen reveals ubiquilin-1 and -2 highly associated with huntingtin inclusions.Oxidative stress, prooxidants, and antioxidants: the interplay.Neuropathologic changes associated with atrial fibrillation in a population-based autopsy cohortBlood-based protein biomarkers for diagnosis and classification of neurodegenerative diseases: current progress and clinical potential.Contribution of β-phenethylamine, a component of chocolate and wine, to dopaminergic neurodegeneration: implications for the pathogenesis of Parkinson's disease.Characterization of biometal profiles in neurological disorders.Selective vulnerability of neurons to acute toxicity after proteasome inhibitor treatment: implications for oxidative stress and insolubility of newly synthesized proteins.
P2860
Q22241476-C62A84C5-58FC-4E6B-8CBD-9EA3652EABA1Q24814434-F68DB8C9-E88D-445B-BDDE-90F868FD7F19Q26800212-A3424F8B-1F96-48C9-BE97-86A0E71F4779Q26800952-98B0737E-3F2B-4761-A09E-39857B64A87DQ27641418-2AE335F4-18DD-48DA-82E4-C986B8C528CBQ27641837-53C450FC-4638-469B-AB26-7D86B0C3D931Q27641905-DE3814CB-C9B8-4943-AE93-481219A18FCBQ28248107-93255E98-9BF9-4B95-8F6E-88419B3E6AA9Q28388335-A608AA50-5140-49FA-803D-10B5870CCC90Q30446460-737590E2-18BA-4C09-AEC9-229AC0EC5D3AQ30573637-9D063188-9F5F-40BA-B602-4EDE7D2DBB61Q33235503-C69C5CD8-B51F-4791-BAD3-50473CFDBE8BQ33317768-C0E36E79-E3B4-405B-9B13-F0DDBFF70896Q33762153-D0DB4A30-68AE-4FEE-A05D-43C526A0F1D8Q34094532-FE8CBF11-82E3-4035-A392-1A635DD18149Q34201730-CADC1349-CE1E-410E-9BF4-D17D17D5848CQ34211735-B6BD3B2F-629F-4C1F-BDB2-43D867FF836FQ34510165-12CB3BA2-6DF6-46E9-85C1-50DEF600EABEQ34536096-3B6687B6-AB9A-4840-B13D-809E6BB25868Q34675135-ECFAC0E5-15A0-4651-8484-8931A9FD4CE1Q34795190-4673961B-115C-4CAB-8058-CD760B6FA57EQ34998995-EF2E5479-2A09-4E45-A673-F45851D9D69CQ35086148-FE9449E0-2B7A-49BB-8310-36BA119E0B2AQ35165389-60E043D7-594B-43DE-B8AF-1AB852739BB7Q35234117-33404CD5-52F9-4E12-8CBA-548B6AD8C719Q35795120-F960EF00-AD61-4529-BA58-E118EDBD24C1Q36335097-DBDB05C9-7DE0-45EC-ADD7-60E94BA10823Q36457072-A1FCB918-B3ED-4A02-ACB4-CC71A39F239AQ36616338-D2815B18-2C53-417F-BA0F-F3C3796CD506Q36872892-ACBC9341-D816-4E15-A6AC-B86D8BEEB074Q36974613-6F9C0734-4795-48DE-8C72-CF96C7286817Q37279897-88618DEB-FAED-4CBC-9566-B03DB0092B26Q37352061-34810C63-8D13-401E-9916-51A31559F744Q37555526-2603B787-EAC1-4A31-A694-3D16A55D6D2FQ37577377-8697E435-8F2F-40E4-A898-6F8D241189D6Q37709616-240C95CB-1DEC-4202-846E-CC98D3D62E46Q37881948-356698D0-7B21-40DA-96DB-B0BAF80D6C75Q38098089-86C3F021-B5FA-4411-BF47-C59AFAEFB175Q38197094-B4479C54-15C3-49BA-9587-761F9155436FQ38506874-33487448-CDEB-4A6A-BC98-4B45959EAEB1
P2860
The relationship between oxidative/nitrative stress and pathological inclusions in Alzheimer's and Parkinson's diseases.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
The relationship between oxida ...... er's and Parkinson's diseases.
@ast
The relationship between oxida ...... er's and Parkinson's diseases.
@en
The relationship between oxida ...... er's and Parkinson's diseases.
@nl
type
label
The relationship between oxida ...... er's and Parkinson's diseases.
@ast
The relationship between oxida ...... er's and Parkinson's diseases.
@en
The relationship between oxida ...... er's and Parkinson's diseases.
@nl
prefLabel
The relationship between oxida ...... er's and Parkinson's diseases.
@ast
The relationship between oxida ...... er's and Parkinson's diseases.
@en
The relationship between oxida ...... er's and Parkinson's diseases.
@nl
P2093
P1476
The relationship between oxida ...... er's and Parkinson's diseases.
@en
P2093
Benoit I Giasson
Harry Ischiropoulos
Virginia M-Y Lee
P304
P356
10.1016/S0891-5849(02)00804-3
P577
2002-06-01T00:00:00Z